Author

Jenna Sherry

Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases

Observed institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases

ORCID: 0000-0001-9257-9520

Observed ORCID: 0000-0001-9257-9520

OpenAlex ID: A5116066007

Nasal and systemic immune responses correlate with viral shedding after influenza challenge in people with complex preexisting immunity

2025 · Kathie-Anne Walters, Charles A. Blatti, et al. · Science Translational Medicine · 9

593. Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine

2025 · Luca Tudor Giurgea, Alison Han, et al. · Open Forum Infectious Diseases · 3

Safety and immunogenicity of a BPL-inactivated, whole-virus, universal influenza vaccine: a randomized, double-blinded, double-dummy, placebo-controlled, phase 1 clinical trial

2026 · Luca T. Giurgea, Alison Han, et al. · Nature Communications

Works count: 3

Citation count: 12

H-index: 2

I10-index: